• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

进行性家族性肝内胆汁淤积症(PFIC)1 型、2 型和 3 型:肝脏病理学发现的综述。

Progressive familial intrahepatic cholestasis (PFIC) type 1, 2, and 3: a review of the liver pathology findings.

机构信息

The Lillian and Henry Stratton-Hans Popper Department of Pathology, Mount Sinai School of Medicine, New York, New York 10029, USA.

出版信息

Semin Liver Dis. 2011 Feb;31(1):3-10. doi: 10.1055/s-0031-1272831. Epub 2011 Feb 22.

DOI:10.1055/s-0031-1272831
PMID:21344347
Abstract

Progressive familial intrahepatic cholestatic diseases encompass a group of autosomal recessive hereditary diseases, which usually present in infancy or childhood, with cholestasis of hepatocellular origin. The currently preferred nomenclature for the three PFIC disorders that have been characterized to date is FIC1 deficiency, BSEP deficiency, and MDR3 deficiency, relating to mutations in the specific genes involved in bile acid formation and transport. Since the first description of these diseases, extensive clinical, biochemical, and molecular studies have increased our understanding of the features specific to each one of them. This review focuses mainly on the liver histology, summarizing their characteristic pathologic features, the correlation to specific genotypes, and complications arising with disease progression.

摘要

进行性家族性肝内胆汁淤积症包括一组常染色体隐性遗传性疾病,通常在婴儿期或儿童期发病,以肝细胞来源的胆汁淤积为特征。目前,对于已经确定的三种 PFIC 疾病,首选的命名法是 FIC1 缺乏症、BSEP 缺乏症和 MDR3 缺乏症,与参与胆汁酸形成和转运的特定基因的突变有关。自这些疾病的首次描述以来,广泛的临床、生化和分子研究增加了我们对每种疾病特征的了解。这篇综述主要侧重于肝脏组织病理学,总结其特征性的病理特征、与特定基因型的相关性以及疾病进展引起的并发症。

相似文献

1
Progressive familial intrahepatic cholestasis (PFIC) type 1, 2, and 3: a review of the liver pathology findings.进行性家族性肝内胆汁淤积症(PFIC)1 型、2 型和 3 型:肝脏病理学发现的综述。
Semin Liver Dis. 2011 Feb;31(1):3-10. doi: 10.1055/s-0031-1272831. Epub 2011 Feb 22.
2
Progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症。
Clin Res Hepatol Gastroenterol. 2012 Sep;36 Suppl 1:S26-35. doi: 10.1016/S2210-7401(12)70018-9.
3
[Liver disease associated with hereditary defects of hepatobiliary transporters].[与肝胆转运体遗传性缺陷相关的肝脏疾病]
Ann Pathol. 2010 Dec;30(6):426-31. doi: 10.1016/j.annpat.2010.08.025. Epub 2010 Nov 11.
4
Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy.家族性胆汁淤积症:进行性家族性肝内胆汁淤积症、良性复发性肝内胆汁淤积症和妊娠肝内胆汁淤积症。
Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):541-53. doi: 10.1016/j.bpg.2010.07.010.
5
DHPLC screening for mutations in progressive familial intrahepatic cholestasis patients.应用 DHPLC 技术对进行性家族性肝内胆汁淤积症患者进行基因突变筛查。
J Hum Genet. 2010 May;55(5):308-13. doi: 10.1038/jhg.2010.28. Epub 2010 Apr 23.
6
Progressive familial intrahepatic cholestasis and benign recurrent intrahepatic cholestasis: a review.进行性家族性肝内胆汁淤积症和良性复发性肝内胆汁淤积症:综述
Acta Gastroenterol Belg. 2012 Dec;75(4):405-10.
7
Genetics and Molecular Modeling of New Mutations of Familial Intrahepatic Cholestasis in a Single Italian Center.意大利单一中心家族性肝内胆汁淤积新突变的遗传学与分子建模
PLoS One. 2015 Dec 17;10(12):e0145021. doi: 10.1371/journal.pone.0145021. eCollection 2015.
8
Progressive familial intrahepatic cholestasis. Genetic basis and treatment.进行性家族性肝内胆汁淤积症。遗传基础与治疗。
Clin Liver Dis. 2000 Nov;4(4):753-63. doi: 10.1016/s1089-3261(05)70139-2.
9
ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.对 62 名 γ-谷氨酰转肽酶正常的进行性家族性肝内胆汁淤积症(PFIC)患儿进行 ATP8B1 和 ABCB11 分析:PFIC1 和 PFIC2 之间的表型差异和自然病史。
Hepatology. 2010 May;51(5):1645-55. doi: 10.1002/hep.23539.
10
Progressive familial intrahepatic cholestasis: a personal perspective.进行性家族性肝内胆汁淤积症:个人观点。
Pediatr Dev Pathol. 2000 Mar-Apr;3(2):113-25. doi: 10.1007/s100240050016.

引用本文的文献

1
One Family with Cholestasis: The Twisted Road to the Diagnosis of Pfic 3-Three Case Reports.一例胆汁淤积症家族:PFIC 3诊断的曲折之路——三例病例报告
Reports (MDPI). 2025 Mar 17;8(1):33. doi: 10.3390/reports8010033.
2
Genetic Variants and Long-Term Outcomes in Korean Children with Progressive Familial Intrahepatic Cholestasis.韩国进行性家族性肝内胆汁淤积症儿童的基因变异与长期预后
Pediatr Gastroenterol Hepatol Nutr. 2025 Jul;28(4):245-255. doi: 10.5223/pghn.2025.28.4.245. Epub 2025 Jul 7.
3
Immunohistochemistry in Progressive Familial Intrahepatic Cholestasis (PFIC): Bridging Gap Between Morphology and Genetics.
进行性家族性肝内胆汁淤积症(PFIC)中的免疫组织化学:弥合形态学与遗传学之间的差距
J Clin Exp Hepatol. 2025 Sep-Oct;15(5):102562. doi: 10.1016/j.jceh.2025.102562. Epub 2025 Mar 28.
4
Clinical symptoms, biochemistry, and liver histology during the native liver period of progressive familial intrahepatic cholestasis type 2.进行性家族性肝内胆汁淤积症 2 型在其原生肝脏期的临床症状、生物化学和肝脏组织学表现。
Orphanet J Rare Dis. 2024 Feb 10;19(1):57. doi: 10.1186/s13023-024-03080-6.
5
Progressive Familial Intrahepatic Cholestasis: A Descriptive Study in a Tertiary Care Center.进行性家族性肝内胆汁淤积症:在一家三级医疗中心的描述性研究。
Int J Hepatol. 2023 Jul 20;2023:1960152. doi: 10.1155/2023/1960152. eCollection 2023.
6
A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report.3 型进行性家族性肝内胆汁淤积症的一名女性患者,其致病原因为 ABCB4 基因突变杂合子,经熊去氧胆酸治疗后肝硬化得到改善:病例报告。
BMC Med Genomics. 2023 Jul 25;16(1):171. doi: 10.1186/s12920-023-01602-y.
7
Molecular and Clinical Links between Drug-Induced Cholestasis and Familial Intrahepatic Cholestasis.药物性胆汁淤积与家族性肝内胆汁淤积的分子和临床联系。
Int J Mol Sci. 2023 Mar 18;24(6):5823. doi: 10.3390/ijms24065823.
8
Is microRNA-33 an Appropriate Target in the Treatment of Atherosclerosis?miR-33 是否是动脉粥样硬化治疗的合适靶点?
Nutrients. 2023 Feb 10;15(4):902. doi: 10.3390/nu15040902.
9
Case series of progressive familial intrahepatic cholestasis type 3: Characterization of variants in in China.3型进行性家族性肝内胆汁淤积症的病例系列:中国患者的变异特征分析
Front Med (Lausanne). 2022 Dec 8;9:962408. doi: 10.3389/fmed.2022.962408. eCollection 2022.
10
Clinical outcomes of surgical management for rare types of progressive familial intrahepatic cholestasis: a case series.罕见类型进行性家族性肝内胆汁淤积症手术治疗的临床结果:病例系列
Surg Case Rep. 2022 Jan 13;8(1):10. doi: 10.1186/s40792-022-01365-1.